Skip to content
NBDC Human Database

No datasets in the cart.

Due to system maintenance, the application system, application review by the Data Access Committee will be unavailable during the following period.
Schedule: October 5th (Mon), 2026, 9:00 - October 7th (Wed), 2026, 15:00 (JST)
We apologize for any inconvenience this may cause and appreciate your understanding.

We are currently receiving a large number of applications for data submission, and the review process is taking longer than usual.We sincerely apologize for the delay and kindly ask for your understanding. When submitting an application, we would greatly appreciate it if you could allow sufficient time for the processing.

Following a change to our organizational structure effective April 1, 2026, this division has been renamed from the "Database Center for Life Science, Joint Support-Center for Data Science Research" to the "Database Division for Life Science (DBCLS), BioData Science Initiative (BSI), National Institute of Genetics (NIG)". Where the former name still appears in the guidelines, please read it as the new name.

Dataset ID

JGAD000656

Type of data
NGS (Exome)
array-CGH
Access criteria
Controlled-access (Type I)
Total data volume
118 GB
File formats
  • BAM
  • TXT
Research
hum0348
Date published
2023-05-16
Date modified
2023-05-16

Analysis method

WES

Materials and participants
ATL (ICD10: C91.5): 8 cases
CD30+ATL cells: 8 samples
CD30-ATL cells: 8 samples
HTLV-1 uninfected lymphocytes: 8 samples
  • Health status
    Affected
  • Subject count
    8 (Individual)
Disease
ATL (C915)
Sample description
DNAs extracted from sorted cells
  • Tissue
    PBMC, Peripheral blood
  • Tumor / normal
    Mixed
Sample provider
N/A
Experimental method
WES
Target
N/A
Reagent kit
SureSelect Human All Exon V6
Fragmentation
Ultrasonic fragmentation (Covaris)
Platform
Illumina NovaSeq 6000
Read type
Paired-end
Read length
150 bp
Reference genome
GRCh38
Mapping
Trimmomatic (v.0.38), DRAGEN Bio-IT Platform (v.3.7.5)
Mapping quality
N/A
Coverage (depth)
83.6x

アレイ CGH

Materials and participants
ATL (ICD10: C91.5): 8 cases
  • Health status
    Affected
  • Subject count
    8 (Individual)
Disease
ATL (C915)
Sample description
DNAs extracted from sorted cells
  • Tissue
    PBMC, Peripheral blood
  • Tumor / normal
    Tumor
Sample provider
N/A
Experimental method
Array CGH
Target
N/A
Reagent kit
SureTag Complete DNA Labeling Kit
Platform
Agilent GenetiSure Cancer Research CGH+SNP Microarray 2 x 400K
QC and filtering
ADM-2 algorithm, Threshokd value: 5.5
Analysis method
Cytogenomics v5.0